1 active not recruiting, 1 not yet recruiting, 1 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Terminated 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow Cutaneous T Cell Lymphomas (CTCL): new trials by email Literature Review of Cutaneous T Cell Lymphomas (CTCL) trials Research Report on Cutaneous T Cell Lymphomas (CTCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies Ossium HPC Marrow, Bone Marrow Transplant, Pre-transplant conditioning - Myeloablative (MAC), Pre-transplant conditioning - Reduced Intensity (RIC) - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | Ossium Health, Inc. | 12 | 2024-08-16 | 2026-09-10 |
| Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma Tavokinogene Telseplasmid (tavo), OncoSec Medical System (OMS) - Cutaneous T Cell Lymphomas (CTCL), Mycosis Fungoides (MF) | Phase 2 | Terminated | OncoSec Medical Incorporated | 2 | 2012-06-08 | 2023-05-15 |
Lymphoma, T-Cell, Cutaneous (3) · Anemia, Refractory, with Excess of Blasts (2) · Hematologic Diseases (2) · Hodgkin Disease (2) · Leukemia (2) · Leukemia, B-Cell (2) · Leukemia, Biphenotypic, Acute (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Hematologic Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Mycosis Fungoides (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma, T-Cell (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Anemia (2) · Anemia, Refractory (2) · Bone Marrow Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Leukemia, Lymphoid (2) · Leukemia, Myeloid (2)
Bone Marrow Transplantation (1) · Cyclophosphamide (1) · Filgrastim (1) · Melphalan (1) · Mesna (1) · Mycophenolic Acid (1) · fludarabine phosphate (1)
Ossium Health, Inc. (2) · OncoSec Medical Incorporated (1)
United States (2)